Details of the Drug Formulations

General Information of Drug (ID: DMM4U9G)

• Drug Name: R0-93877 Drug Info
• Synonyms: Prucalopride; 179474-81-8; UNII-0A09IUW5TP; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide; 0A09IUW5TP; C18H26ClN3O3; CHEMBL117287; R-093877; 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; R 093877; 4-Amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide; 4-Amino-5-chloro-2,3-dihydro-N-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide; R093877; Motegrity; Prucalopride [USAN:INN:BAN]

Indication

Disease Entry	ICD 11	Status	REF
Constipation	DD91.1	Approved	[1]
Irritable bowel syndrome	DD91.0	Approved	[2]

• Cross-matching ID:
  PubChem CID: 3052762
  ChEBI ID: CHEBI:135552
  CAS Number: 179474-81-8
  TTD ID: D04QSJ
  VARIDT ID: DR00187
  ACDINA ID: D01369

Full List of Drug Formulations Containing This Drug

Prucalopride 2 mg tablet

Company	Formulation ID	FDA Description
Takeda Pharmaceuticals America	F23875	Colloidal Silicon Dioxide; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Hypromellose; Lactose Monohydrate; Polyethylene Glycol 3000; Titanium Dioxide; Triacetin; Red Iron Oxide; Yellow Iron Oxide; Fd&C Blue 2

Prucalopride 1 mg tablet

Company	Formulation ID	FDA Description
Takeda Pharmaceuticals America	F23874	Colloidal Silicon Dioxide; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Hypromellose; Lactose Monohydrate; Polyethylene Glycol 3000; Titanium Dioxide; Triacetin

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.